Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19032240 | METHOD FOR PREPARING THEAFLAVIN WITH IMMOBILIZED SUBSTRATE | January 2025 | October 2025 | Allow | 9 | 1 | 0 | Yes | No |
| 18785008 | GRANULE FOR DETECTING OCCULT BLOOD IN PET URINE AND METHOD FOR PREPARING THE SAME | July 2024 | December 2024 | Allow | 5 | 0 | 1 | Yes | No |
| 18582510 | PRODUCTION METHOD OF ENZYMATIC REACTION USING ADENOSINE INSTEAD OF ATP | February 2024 | March 2025 | Allow | 13 | 1 | 0 | Yes | No |
| 18516887 | GRANULE FOR DETECTING OCCULT BLOOD IN PET URINE AND METHOD FOR PREPARING THE SAME | November 2023 | December 2024 | Abandon | 13 | 2 | 0 | No | No |
| 18375171 | COMPOSITIONS AND METHODS FOR REDUCING BLOOD ALCOHOL CONTENT | September 2023 | March 2026 | Abandon | 30 | 1 | 1 | No | No |
| 18373763 | METHOD AND AGENTS FOR DETECTING LUCIFERASE ACTIVITY | September 2023 | July 2025 | Allow | 22 | 1 | 0 | No | No |
| 18351559 | METHOD FOR PRODUCING TERTIARY BETA-HYDROXY-ALPHA-AMINO ACIDS | July 2023 | March 2026 | Allow | 32 | 0 | 0 | Yes | No |
| 18208713 | APPARATUS AND METHOD FOR PRETREATMENT OF MICROBIAL SAMPLES | June 2023 | September 2024 | Abandon | 15 | 2 | 0 | No | No |
| 18253861 | METHOD FOR PREPARING NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND DERIVATIVE THEREOF BY ENZYMATIC-CHEMICAL CASCADE METHOD | May 2023 | May 2024 | Allow | 12 | 1 | 0 | Yes | No |
| 18024502 | STABILIZER FOR COLOR DEVELOPING AGENT AND APPLICATION THEREOF, APPLICATION OF COMPOSITION IN PREPARATION OF STABILIZER, AND KIT | March 2023 | August 2024 | Allow | 17 | 3 | 0 | Yes | No |
| 18112871 | REAGENTS AND METHODS FOR SCREENING MPS I, II, IIIA, IIIB, IVA, VI, AND VII | February 2023 | February 2026 | Allow | 36 | 1 | 0 | No | No |
| 18015938 | THERAPEUTIC MICROBES | January 2023 | March 2026 | Abandon | 38 | 0 | 1 | No | No |
| 17991991 | GLUCOSYL STEVIA COMPOSITIONS | November 2022 | May 2025 | Abandon | 30 | 2 | 0 | No | Yes |
| 18049495 | NICOTINAMIDE RIBOSIDE PRODUCTION IN FILAMENTOUS FUNGI | October 2022 | January 2024 | Allow | 14 | 1 | 1 | Yes | No |
| 17905749 | METHOD TO PRODUCE THE ANTI-MICROBIAL DITERPENOID LEUBETHANOL AND RELATED SERRULATANE-TYPE DITERPENES | September 2022 | March 2025 | Allow | 31 | 0 | 1 | Yes | No |
| 17823530 | Compositions Comprising Probiotic and Prebiotic Components and Mineral Salts, with Lactoferrin | August 2022 | September 2023 | Allow | 13 | 2 | 0 | No | No |
| 17894924 | METHODS FOR SYNTHESIZING ANTICOAGULANT POLYSACCHARIDES | August 2022 | February 2023 | Allow | 5 | 1 | 0 | No | No |
| 17863024 | PHOTON-INDUCED ACCELERATED ENZYMES AND BIOACTIVE COMPOUNDS ACCUMULATION IN BARLEY DURING MALTING | July 2022 | June 2025 | Allow | 35 | 2 | 0 | Yes | No |
| 17854325 | METHODS FOR TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS | June 2022 | May 2024 | Allow | 23 | 1 | 1 | No | No |
| 17788289 | PROSTAGLANDIN PRODUCTION METHOD | June 2022 | June 2024 | Allow | 24 | 2 | 0 | Yes | No |
| 17806208 | Method for Stabilizing Colorimetric Assay for Use with Plucked Human Hair | June 2022 | September 2025 | Abandon | 40 | 3 | 0 | No | No |
| 17777336 | ENZYME MEDIATED PROCESS | May 2022 | January 2024 | Allow | 20 | 0 | 1 | No | No |
| 17740547 | Treatment for Inflammatory Bowel Disease and Radiation-induced Intestinal Injury | May 2022 | January 2026 | Abandon | 44 | 1 | 1 | No | No |
| 17735532 | OPTIMAL RANGE OF SALIVARY MMP-9 CONCENTRATION FOR SCREENING RISK OF PERIODONTITIS, AND METHOD OF ITS APPLICATION FOR SCREENING RISK OF PERIODONTITIS | May 2022 | April 2024 | Abandon | 23 | 1 | 0 | No | No |
| 17706131 | Method for Online Monitoring of Mashing Processes Using Infrared Spectroscopy | March 2022 | December 2023 | Abandon | 20 | 0 | 1 | No | No |
| 17760705 | NOVEL POLYPEPTIDES FOR PRODUCING ALBICANOL AND/OR DRIMENOL COMPOUNDS | March 2022 | December 2025 | Allow | 45 | 2 | 1 | Yes | No |
| 17637987 | LACTOCOCCAL EXPRESSION OF IL-35 FOR TREATMENT OF DISEASE | February 2022 | February 2026 | Allow | 47 | 1 | 1 | No | No |
| 17677931 | AMPHOTERICIN B AND BETA-1,3-GLUCANASE LOADED BI-FUNCTIONAL NANO-SYSTEM WITH BOTH TARGETS, PREPARATION METHOD AND APPLICATION THEREOF | February 2022 | July 2023 | Allow | 17 | 1 | 0 | No | No |
| 17591171 | COPPER SUPPLEMENTATION FOR CONTROL OF GLYCOSYLATION IN MAMMALIAN CELL CULTURE PROCESS | February 2022 | April 2023 | Allow | 15 | 1 | 0 | No | No |
| 17555438 | Triterpene Production | December 2021 | May 2024 | Abandon | 29 | 4 | 0 | No | No |
| 17550084 | REAL-TIME MONITORING OF MICROBIAL CONTAMINATION IN OILFIELD DRILLING FLUIDS AND CEMENT | December 2021 | December 2023 | Abandon | 24 | 1 | 0 | No | No |
| 17456177 | NOVEL SPORICHTHYACEAE MICROORGANISM AND USE THEREOF | November 2021 | January 2023 | Allow | 14 | 1 | 0 | No | No |
| 17493477 | COMPOSITIONS AND METHODS FOR SIMULTANEOUS INACTIVATION OF ALKALINE PHOSPHATASE AND PEROXIDASE ENZYMES DURING AUTOMATED MULTIPLEX TISSUE STAINING ASSAYS | October 2021 | January 2024 | Allow | 27 | 1 | 1 | No | No |
| 17412031 | AMPHOTERIC GLYCOLIPID BIOSURFACTANT AND ITS PREPARATION METHOD | August 2021 | August 2025 | Abandon | 47 | 1 | 1 | No | No |
| 17376354 | METHODS FOR SYNTHESIZING ANTICOAGULANT POLYSACCHARIDES | July 2021 | September 2022 | Allow | 14 | 1 | 1 | No | No |
| 17422586 | CHIMERIC PROTEIN AND RELATED GENIC TRANSFER TECHNOLOGY | July 2021 | September 2024 | Allow | 38 | 0 | 0 | Yes | No |
| 17421718 | USE OF CELL WALL SKELETON OF ISOLATED RHODOCOCCUS RUBER FOR PREPARING HUMAN PAPILLOMAVIRUS INFECTION TREATMENT DRUG | July 2021 | June 2024 | Allow | 36 | 0 | 1 | Yes | No |
| 17418124 | COMBINATIONS OF ENGINEERED ANTIMICROBIAL PROBIOTICS FOR TREATMENT OF GASTROINTESTINAL TRACT PATHOGENS | June 2021 | January 2026 | Allow | 55 | 2 | 1 | No | No |
| 17312350 | FAMIN Assay Methods | June 2021 | September 2024 | Allow | 40 | 1 | 0 | No | No |
| 17311835 | A Method for Enzymatic Resolution of Chiral Substances | June 2021 | April 2025 | Allow | 46 | 1 | 0 | Yes | No |
| 17303513 | METHOD FOR EVALUATING METABOLIZABLE ENERGY IN GOOSE DIET BY USING A SIMULATIVE DIGESTION GROSS ENERGY TECHNIQUE | June 2021 | September 2023 | Allow | 28 | 1 | 0 | Yes | No |
| 17296772 | BIOCATALYTIC TECHNIQUES | May 2021 | September 2023 | Allow | 28 | 0 | 0 | Yes | No |
| 17206944 | IMMOBILIZED THERMOSTABLE TREHALOSE SYNTHASE AND METHOD FOR PRODUCING TREHALOSE AND TREHALULOSE BY USING SAME | March 2021 | January 2024 | Allow | 34 | 2 | 1 | Yes | No |
| 17276820 | METHOD FOR THE BIOTECHNOLOGICAL PRODUCTION OF THE BLUE-GREEN FUNGUS PIGMENT XYLINDEIN | March 2021 | August 2023 | Allow | 29 | 1 | 0 | No | No |
| 17167136 | Compositions and methods for ordered and continuous complementary DNA (cDNA) synthesis across non-continuous templates | February 2021 | June 2024 | Allow | 40 | 0 | 1 | Yes | No |
| 17164010 | BIOSYNTHESIS OF PREPARING NICOTINAMIDE MONONUCLEOTIDE AND DERIVATIVES THEREOF | February 2021 | October 2023 | Abandon | 32 | 0 | 1 | No | No |
| 17159902 | METAL NANOPARTICLES FOR GLUCOSE DETECTION AND GLUCOSE DETECTION METHOD USING THE SAME | January 2021 | April 2023 | Allow | 27 | 1 | 0 | No | No |
| 17261426 | METHOD FOR DECONTAMINATING ENVIRONMENT POLLUTED WITH PETROLEUM-RELATED MATERIAL, AND MATERIAL USED | January 2021 | July 2024 | Abandon | 42 | 0 | 1 | No | No |
| 17149354 | COMPOSITIONS AND METHODS FOR REDUCING BLOOD ALCOHOL CONTENT | January 2021 | May 2023 | Allow | 28 | 1 | 0 | No | No |
| 17260168 | ENZYMATIC PREPARATION OF GLUCOSAMINE | January 2021 | May 2024 | Allow | 41 | 1 | 1 | No | No |
| 17144422 | COMPOSITIONS, DEVICES, KITS AND METHODS USEFUL FOR REMOVAL OF PHOSPHOLIPIDS | January 2021 | February 2025 | Abandon | 49 | 3 | 1 | No | No |
| 17257792 | ENZYMATIC SYNTHESIS OF 4'-ETHYNYL NUCLEOSIDE ANALOGS | January 2021 | March 2024 | Allow | 39 | 1 | 1 | No | No |
| 17256364 | Genetically Engineered Bacteria, Its Construction Method And Its Application In Producing Nad+ Method | December 2020 | September 2024 | Allow | 45 | 2 | 1 | No | No |
| 17124740 | CHEMOENZYMATIC SYNTHESIS OF TREHALOSE ANALOGUES | December 2020 | August 2023 | Allow | 32 | 1 | 0 | No | No |
| 17253314 | METHOD OF SELECTING A POLYPEPTIDE OF INTEREST | December 2020 | November 2025 | Allow | 59 | 3 | 1 | No | No |
| 17123226 | Method for Producing Long-chain Glycosylated Genistein | December 2020 | October 2021 | Allow | 9 | 0 | 0 | Yes | No |
| 17076012 | Composition for Promoting Increase in Subcutaneous Tissue and Subcutaneous Adipose Tissue | October 2020 | February 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17074342 | SEPARATION OF ACETATE FROM FERMENTATION BROTH | October 2020 | January 2025 | Abandon | 51 | 2 | 1 | No | No |
| 17027997 | Biogas production with select macro algae and nanoparticles added to anaerobic digester feedstock | September 2020 | April 2023 | Abandon | 30 | 1 | 0 | No | No |
| 16975894 | Method For Preparing Hexahydrofuro-Furanol Derivative, Intermediate Thereof And Preparation Method Thereof | August 2020 | September 2022 | Allow | 25 | 2 | 1 | No | No |
| 16983750 | GLUCOSYL STEVIA COMPOSITION | August 2020 | October 2023 | Allow | 39 | 2 | 0 | No | No |
| 16945559 | MODIFIED HOST CELLS FOR HIGH EFFICIENCY PRODUCTION OF VANILLIN | July 2020 | September 2025 | Allow | 60 | 3 | 1 | Yes | No |
| 16907381 | FAECALIBACTERIUM PRAUSNITZII STRAINS FOR TREATING AND PREVENTING GASTROINTESTINAL PAIN | June 2020 | March 2023 | Allow | 32 | 1 | 0 | Yes | No |
| 16903028 | COATINGS CONTAINING POLYMER MODIFIED ENZYME FOR STABLE SELF-CLEANING OF ORGANIC STAINS | June 2020 | March 2024 | Allow | 45 | 2 | 1 | No | No |
| 16888779 | METHOD FOR EXTRACTING CITRULLINE FROM WATERMELON | May 2020 | September 2020 | Allow | 4 | 1 | 0 | No | No |
| 16881479 | METHOD FOR PRETREATMENT OF MICROBIAL CELLS | May 2020 | March 2023 | Allow | 33 | 1 | 1 | No | No |
| 16855562 | METHOD OF PRODUCING A PECTIC POLYSACCHARIDE ISOLATE ENRICHED IN RHAMNOGALACTURONAN-I | April 2020 | November 2024 | Allow | 55 | 3 | 1 | Yes | No |
| 16649771 | PRODUCTION OF TRANS-RETINAL | March 2020 | October 2024 | Abandon | 55 | 3 | 1 | No | No |
| 16820845 | COMPOSITION FOR TREATMENT OF JOINT DISEASE AND METHOD THEREOF | March 2020 | May 2022 | Abandon | 26 | 1 | 0 | No | No |
| 16647038 | ONLINE BIOMASS CAPACITANCE MONITORING DURING LARGE SCALE PRODUCTION OF POLYPEPTIDES OF INTEREST | March 2020 | July 2024 | Abandon | 52 | 1 | 0 | No | No |
| 16640231 | METHOD FOR MEASURING CHOLESTEROL IN LOW-DENSITY LIPOPROTEIN, MEASUREMENT REAGENT, AND MEASUREMENT KIT | February 2020 | September 2024 | Allow | 55 | 2 | 1 | No | No |
| 16773304 | METHOD AND AGENTS FOR DETECTING LUCIFERASE ACTIVITY | January 2020 | June 2023 | Allow | 41 | 2 | 0 | Yes | Yes |
| 16741627 | METHOD AND COMPOSITION FOR PRODUCING ENHANCED ANTI-INFLAMMATORY/ANTI-CATABOLIC AND REGENERATIVE AGENTS FROM AUTOLOGOUS PHYSIOLOGICAL FLUID | January 2020 | February 2024 | Allow | 49 | 5 | 1 | Yes | No |
| 16629643 | MICROBIAL CELLS FOR SPERMIDINE PRODUCTION | January 2020 | June 2025 | Allow | 60 | 5 | 1 | Yes | No |
| 16724682 | COATINGS CONTAINING ENZYME FOR STABLE SELF-CLEANING OF ORGANIC STAINS | December 2019 | August 2022 | Allow | 32 | 1 | 1 | No | No |
| 16715975 | CULTURE DEVICE FOR LACTIC ACID BACTERIA | December 2019 | March 2022 | Abandon | 27 | 1 | 0 | No | No |
| 16622852 | PRODUCTION METHOD OF ENZYMATIC REACTION USING ADENOSINE INSTEAD OF ATP | December 2019 | November 2023 | Allow | 47 | 2 | 0 | Yes | No |
| 16705720 | METHOD FOR EVALUATION OF DRUG EFFICACY OF A MEDICINE HAVING A THERAPEUTIC OR PREVENTIVE EFFECT AGAINST A DISEASE RELATED TO EL ACTIVITY AND A METHOD FOR SCREENING AN INHIBITOR OF EL ACTIVITY | December 2019 | March 2022 | Abandon | 28 | 1 | 0 | No | No |
| 16616633 | Use of Terminal Transferase Enzyme in Nucleic Acid Synthesis | November 2019 | January 2024 | Allow | 49 | 2 | 0 | No | No |
| 16615865 | Enzymatic DNA Synthesis Using the Terminal Transferase Activity of Template-Dependent DNA Polymerases | November 2019 | February 2024 | Abandon | 51 | 2 | 1 | No | No |
| 16613663 | METHOD OF PRODUCING 2'-FUCOSYLLACTOSE USING FUCOSYLTRANSFERASE DERIVED FROM PSEUDOPEDOBACTER SALTANS | November 2019 | September 2021 | Allow | 23 | 0 | 0 | Yes | No |
| 16612065 | IMPROVED METHODS FOR PRODUCING lSOBUTENE FROM 3-METHYLCROTONIC ACID | November 2019 | February 2024 | Allow | 52 | 1 | 1 | Yes | No |
| 16605993 | METHOD AND ENZYME FOR PREPARATION OF ENZYME-MODIFIED STEVIA SUGAR AND USE OF ENZYME-MODIFIED STEVIA SUGAR | October 2019 | February 2022 | Allow | 28 | 0 | 1 | Yes | No |
| 16599496 | FOOD COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH STRAINS OF LACTIC ACID BACTERIA AND METHOD FOR MODULATING BLOOD GLUCOSE | October 2019 | November 2022 | Allow | 37 | 2 | 0 | No | No |
| 16500497 | REGIOSELECTIVE HYDROXYLATION OF ISOPHORONE | October 2019 | March 2024 | Allow | 54 | 2 | 1 | No | No |
| 16589933 | SYSTEMS AND METHODS FOR CULTIVATING AND DISTRIBUTING AQUATIC ORGANISMS | October 2019 | August 2022 | Allow | 34 | 1 | 0 | Yes | No |
| 16495435 | METHOD FOR DETECTING ATP BY USING PERSONAL BLOOD GLUCOSE METER | September 2019 | April 2023 | Abandon | 43 | 3 | 0 | No | No |
| 16563260 | PROCESSES FOR OBTAINING MICROBIAL OIL FROM MICROBIAL CELLS | September 2019 | May 2024 | Allow | 57 | 3 | 1 | No | Yes |
| 16543433 | REGULATION OF POLYMERASE USING COFACTOR OXIDATION STATES | August 2019 | February 2023 | Allow | 42 | 1 | 1 | Yes | No |
| 16539961 | MICROBIAL ELECTRO-PHOTOSYNTHESIS | August 2019 | October 2019 | Allow | 2 | 0 | 0 | Yes | No |
| 16464459 | AGLYCONE PRODUCTION PROMOTER | August 2019 | December 2022 | Abandon | 43 | 2 | 0 | Yes | No |
| 16482608 | NOVEL 5'-INOSINIC ACID DEHYDROGENASE AND METHOD OF PREPARING 5'-INOSINIC ACID USING THE SAME | July 2019 | March 2021 | Allow | 19 | 0 | 0 | Yes | No |
| 16515415 | Method for Producing Heparosan Compound Having Isomerized Hexuronic Acid Residue | July 2019 | January 2023 | Allow | 42 | 1 | 1 | Yes | No |
| 16467805 | GLUCOSYL STEVIA COMPOSITIONS | June 2019 | December 2022 | Abandon | 43 | 1 | 0 | No | No |
| 16424230 | GLUCOSYL STEVIA COMPOSITION | May 2019 | May 2023 | Allow | 48 | 5 | 1 | Yes | No |
| 16462899 | AMYOTROPHIC LATERAL SCLEROSIS DIAGNOSTIC COMPOSITION USING ACID SPHINGOMYELINASE, AND METHOD FOR DETECTING DIAGNOSTIC MARKERS | May 2019 | August 2022 | Allow | 39 | 1 | 0 | Yes | No |
| 16341734 | Novel Plant-Growth Promoting Bacteria and the Use Thereof | April 2019 | January 2023 | Abandon | 45 | 2 | 1 | Yes | No |
| 16381654 | PROTEIN MODIFICATION OF LIVING CELLS USING SORTASE | April 2019 | June 2022 | Allow | 38 | 0 | 1 | No | No |
| 16369939 | METHOD TO SCREEN COMPOUNDS FOR ANTIFUNGAL ACTIVITY AND PHARMACEUTICAL COMPOSITIONS AND METHODS TO TREAT FUNGAL DISEASES BY INHIBITING SPORE GERMINATION | March 2019 | January 2024 | Allow | 57 | 2 | 1 | No | No |
| 16337688 | COMPOSITION FOR PRODUCTION OF GINSENOSIDE COMPOUND K COMPRISING HIGH TEMPERATURE alpha-L-ARABINOFURANOSIDASE, AND METHOD FOR PREPARING GINSENDOSIDE COMPOUND K | March 2019 | June 2022 | Abandon | 38 | 2 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner CONSTANTINE, CHARLES Z.
With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner CONSTANTINE, CHARLES Z works in Art Unit 1657 and has examined 466 patent applications in our dataset. With an allowance rate of 58.2%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 34 months.
Examiner CONSTANTINE, CHARLES Z's allowance rate of 58.2% places them in the 18% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by CONSTANTINE, CHARLES Z receive 1.79 office actions before reaching final disposition. This places the examiner in the 40% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by CONSTANTINE, CHARLES Z is 34 months. This places the examiner in the 42% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +51.7% benefit to allowance rate for applications examined by CONSTANTINE, CHARLES Z. This interview benefit is in the 94% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 26.1% of applications are subsequently allowed. This success rate is in the 42% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 39.8% of cases where such amendments are filed. This entry rate is in the 61% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 133.3% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 85% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 78.9% of appeals filed. This is in the 71% percentile among all examiners. Of these withdrawals, 73.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 65.0% are granted (fully or in part). This grant rate is in the 70% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 1.1% of allowed cases (in the 68% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.7% of allowed cases (in the 58% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.